Literature DB >> 3881608

Dietary therapy slows the return of hypertension after stopping prolonged medication.

H G Langford, M D Blaufox, A Oberman, C M Hawkins, J D Curb, G R Cutter, S Wassertheil-Smoller, S Pressel, C Babcock, J D Abernethy.   

Abstract

This study asks whether prolonged antihypertensive therapy will "cure" a substantial percent of rigorously treated hypertensive patients and whether nutritional change will add an antihypertensive effect and reduce the relapse rate. Of 584 eligible patients normotensive while receiving therapy, 496 were randomized into control and discontinued-medication groups with and without dietary intervention. At 56 weeks, 50% of those who were no longer receiving medication remained normotensive by study criteria. Randomization either to weight-loss group (mean loss of 4.5 kg [10 lb]) or to sodium-restriction group (mean reduction of 40 mEq/day) increased the likelihood of remaining without drug therapy, with an adjusted odds ratio of 2.17 for the sodium group and 3.43 for the weight group. Highest success rates were in the nonoverweight mild hypertensives with sodium restriction (78%) and the overweight mild hypertensives who were reducing their weight (72%). These data demonstrate that weight loss or sodium restriction, in hypertensives controlled for five years, more than doubles success in withdrawal of drug therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881608

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  37 in total

1.  Culturally-sensitive weight loss program produces significant reduction in weight, blood pressure, and cholesterol in eight weeks.

Authors:  J D Ard; R Rosati; E Z Oddone
Journal:  J Natl Med Assoc       Date:  2000-11       Impact factor: 1.798

Review 2.  Prehypertension: a possible target for antihypertensive medication.

Authors:  S D Nesbitt; S Julius
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 3.  Risks versus benefits of withdrawing antihypertensive therapy.

Authors:  H P Schobel; R E Schmieder; F H Messerli
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 4.  Economic factors in the initiation of antihypertensive therapy.

Authors:  I Kawachi
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

Review 5.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

6.  Clinical predictors of treatment reduction in hypertensive patients.

Authors:  J F Steiner; S D Fihn; T D Koepsell; B Blair; K Kelleher; D D'Alessandro; T S Inui
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

7.  Does Antihypertensive Therapy Need to be Life-Long?

Authors:  J Lemelin
Journal:  Can Fam Physician       Date:  1989-09       Impact factor: 3.275

Review 8.  Dietary electrolytes and hypertension in the elderly.

Authors:  T Rosenthal; A Shamiss; E Holtzman
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 9.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

10.  Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis.

Authors:  Leslea Peirson; James Douketis; Donna Ciliska; Donna Fitzpatrick-Lewis; Muhammad Usman Ali; Parminder Raina
Journal:  CMAJ Open       Date:  2014-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.